Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome-Reference-Cited by-同舟云学术

Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome

Published:2021-01-15 Issue:2 Volume:72 Page:562-572
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Vojnović Milutinović Danijela,Teofilović Ana,Veličković Nataša,Brkljačić Jelena,Jelača Sanja,Djordjevic Ana,Macut Djuro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-020-02600-1.pdf

Reference43 articles.

1. G. Conway, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, S. Franks, A. Gambineri, F. Kelestimur, D. Macut, D. Micic, R. Dewailly, M. Pfeifer, D. Pignatelli, M. Pugeat, B.O. Yildiz, E. P. S. I. Group, The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur. J. Endocrinol. 171(4), P1–P29 (2014). https://doi.org/10.1530/EJE-14-0253

2. H. Jones, V.S. Sprung, C.J. Pugh, C. Daousi, A. Irwin, N. Aziz, V.L. Adams, E.L. Thomas, J.D. Bell, G.J. Kemp, D.J. Cuthbertson, Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 97(10), 3709–3716 (2012). https://doi.org/10.1210/jc.2012-1382

3. D. Macut, J. Bjekić-Macut, S. Livadas, O. Stanojlović, D. Hrncic, A. Rašić-Marković, D. Vojnović Milutinović, V. Mladenović, Z. Andrić, Nonalcoholic fatty liver disease in patients with polycystic ovary syndrome. Curr. Pharm. Des. 24(38), 4593–4597 (2018). https://doi.org/10.2174/1381612825666190117100751

4. A.L.L. Rocha, L.C. Faria, T.C.M. Guimaraes, G.V. Moreira, A.L. Candido, C.A. Couto, F.M. Reis, Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. J. Endocrinol. Investig. 40(12), 1279–1288 (2017). https://doi.org/10.1007/s40618-017-0708-9

5. J.M. Hazlehurst, J.W. Tomlinson, Non-alcoholic fatty liver disease in common endocrine disorders. Eur. J. Endocrinol. 169(2), R27–R37 (2013). https://doi.org/10.1530/EJE-13-0296

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal nutrient metabolism in the liver during pregnancy;Frontiers in Endocrinology;2024-03-20

2. Oral administration of the methanolic extract of Abutilon indicum (L.) Sweet seed proves effective in reducing cystic follicles and restoring the metabolic profile of Wistar albino rats with letrozole-induced polycystic ovarian syndrome;Pharmacological Research - Modern Chinese Medicine;2024-03

3. The Effect of Testosterone on Serum Lipid Profiles, Glucose, Insulin and Leptin: A Experimental Study Based Animal Model;GALEN MED J;2024

4. Glucocorticoid Receptor Antagonism Improves Glucose Metabolism in a Mouse Model of Polycystic Ovary Syndrome;Journal of the Endocrine Society;2023-12-01

5. Androgen signalling in the ovaries and endometrium;Molecular Human Reproduction;2023-05-12